Rainier Group Investment Advisory LLC Has $427,000 Stock Holdings in UnitedHealth Group Inc (NYSE:UNH)

Rainier Group Investment Advisory LLC increased its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 8.6% during the 2nd quarter, Holdings Channel reports. The institutional investor owned 1,750 shares of the healthcare conglomerate’s stock after acquiring an additional 139 shares during the quarter. UnitedHealth Group comprises about 0.2% of Rainier Group Investment Advisory LLC’s holdings, making the stock its 25th largest position. Rainier Group Investment Advisory LLC’s holdings in UnitedHealth Group were worth $427,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Eastern Bank lifted its position in shares of UnitedHealth Group by 2.0% in the 2nd quarter. Eastern Bank now owns 69,088 shares of the healthcare conglomerate’s stock worth $16,858,000 after purchasing an additional 1,375 shares during the period. Enterprise Bank & Trust Co acquired a new position in shares of UnitedHealth Group in the 1st quarter worth approximately $3,785,000. Private Advisors LLC lifted its position in shares of UnitedHealth Group by 57.9% in the 1st quarter. Private Advisors LLC now owns 6,501 shares of the healthcare conglomerate’s stock worth $1,607,000 after purchasing an additional 2,385 shares during the period. Capital Investment Advisors LLC lifted its position in shares of UnitedHealth Group by 26.2% in the 2nd quarter. Capital Investment Advisors LLC now owns 6,379 shares of the healthcare conglomerate’s stock worth $1,556,000 after purchasing an additional 1,323 shares during the period. Finally, Berkeley Capital Partners LLC lifted its position in shares of UnitedHealth Group by 7.4% in the 2nd quarter. Berkeley Capital Partners LLC now owns 2,220 shares of the healthcare conglomerate’s stock worth $542,000 after purchasing an additional 153 shares during the period. Hedge funds and other institutional investors own 85.66% of the company’s stock.

UNH has been the topic of a number of recent analyst reports. Raymond James boosted their price target on shares of UnitedHealth Group from $265.00 to $300.00 and gave the stock a “buy” rating in a research report on Friday, July 19th. ValuEngine downgraded shares of UnitedHealth Group from a “hold” rating to a “sell” rating in a research report on Thursday, September 5th. Cantor Fitzgerald set a $310.00 price target on shares of UnitedHealth Group and gave the stock a “buy” rating in a research report on Friday, July 19th. Morgan Stanley boosted their price target on shares of UnitedHealth Group from $285.00 to $298.00 and gave the stock an “overweight” rating in a research report on Friday, July 12th. Finally, Oppenheimer set a $312.00 price target on shares of UnitedHealth Group and gave the stock a “buy” rating in a research report on Friday, July 19th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and seventeen have given a buy rating to the company’s stock. UnitedHealth Group has an average rating of “Buy” and a consensus price target of $291.61.

Shares of NYSE:UNH traded up $0.04 during mid-day trading on Friday, hitting $232.89. The company had a trading volume of 5,879,235 shares, compared to its average volume of 3,740,347. The firm has a fifty day moving average price of $237.87 and a 200 day moving average price of $242.73. The company has a market capitalization of $218.54 billion, a PE ratio of 18.08, a price-to-earnings-growth ratio of 1.23 and a beta of 0.62. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.67 and a quick ratio of 0.67. UnitedHealth Group Inc has a one year low of $208.07 and a one year high of $287.94.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, July 18th. The healthcare conglomerate reported $3.60 earnings per share for the quarter, beating the consensus estimate of $3.46 by $0.14. The company had revenue of $60.60 billion during the quarter, compared to analyst estimates of $60.59 billion. UnitedHealth Group had a net margin of 5.51% and a return on equity of 25.20%. UnitedHealth Group’s revenue for the quarter was up 8.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $3.14 EPS. Research analysts expect that UnitedHealth Group Inc will post 14.84 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be paid a $1.08 dividend. The ex-dividend date of this dividend is Friday, September 13th. This represents a $4.32 annualized dividend and a dividend yield of 1.85%. UnitedHealth Group’s dividend payout ratio is currently 33.54%.

In other UnitedHealth Group news, Director William C. Ballard, Jr. sold 12,000 shares of the business’s stock in a transaction on Tuesday, July 23rd. The shares were sold at an average price of $255.31, for a total transaction of $3,063,720.00. Following the completion of the sale, the director now owns 61,309 shares in the company, valued at approximately $15,652,800.79. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Richard T. Burke sold 2,000 shares of the business’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $231.50, for a total transaction of $463,000.00. Following the sale, the director now owns 187,979 shares of the company’s stock, valued at approximately $43,517,138.50. The disclosure for this sale can be found here. Insiders sold a total of 21,500 shares of company stock valued at $5,340,620 in the last quarter. 0.87% of the stock is currently owned by company insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

See Also: What is a Tariff?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit